P-286 Azacitidine pretreatment followed by non-myeloablative SCT in patients with high-risk myelodysplastic syndrome: Prospective, open label, multicenter, phase II trial

Autor: Kim, H., Jae-Sook, A., Kim, Y., Min, Y.H., Kim, J.S., Jang, J.H., Jung, C.W., Kim, I.H., Yoon, H.J., Lee, H.G., Sohn, S.K., Moon, J.H., Kim, Y.J., Won, J.H., Bang, S.M., Chung, J.S., Mun, Y.C.
Zdroj: In Leukemia Research May 2013 37 Supplement 1:S151-S151
Databáze: ScienceDirect